# Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions

> **NCT06558838** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 40 (actual)

## Conditions studied

- Herpes Simplex Oral

## Interventions

- **DRUG:** acyclovir-penciclovir cream
- **DRUG:** Abreva

## Key facts

- **NCT ID:** NCT06558838
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-19
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558838, "Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06558838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*